The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Key Takeaways Moderna's combo shot for flu and COVID-19 showed strong antibody responsesThe U.S. Food and Drug Administration ...

What Happened? A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5% ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

The Trump administration stopped the study. Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against ...

Side effects were injection site pain, fatigue and headaches. Moderna previously reported a summary of the results from the company-sponsored trial in 8,000 people. The mRNA technology is used in ...